FDA warns biotech firm over cancer drug claims
The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.
Mar 29, 2026
0
3
Urogenital Diseases: News and Research on Urogenital Neoplasms
MeSH tree: C12.050.351.937
Home testing kits could bridge the cervical screening gap for disabled women, new study finds
Home testing kits that screen for cervical cancer risk could be a game-changer for reducing health inequalities for physically disabled women, according to a new study revealing that over 50% would prefer a self-test over ...
Mar 26, 2026
0
3
Chronic stress linked to faster cancer progression in multiple tumor types
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic ...
Mar 24, 2026
0
5
HPV self-test boosts cervical cancer screening 'across the board,' study confirms
Making human papillomavirus (HPV) self-testing available to all women increases the number of people screened for cervical cancer, a new study led by researchers from Te Herenga Waka—Victoria University of Wellington has ...
Mar 19, 2026
0
8
Study identifies inflammatory immune pathway driving immunotherapy resistance in bladder cancer
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well to immunotherapy. Their ...
Mar 18, 2026
0
5
Observational analyses can complement randomized clinical trial findings for the study of HPV vaccine effectiveness
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new European study has shown that carefully designed observational studies can produce robust and reliable ...
Mar 17, 2026
0
10
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant ...
Mar 16, 2026
0
9
Timely scan could save lives of emergency department patients with blood in urine
One in ten emergency patients with visible blood in their urine dies within three months of presenting at hospital emergency departments, new research has found. The WASHOUT study, presented at the European Association of ...
Mar 15, 2026
0
11
IVF not linked to higher overall cancer rates, but study shows differences in some cancers
Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published in JAMA Network Open, analyzed ...
Mar 10, 2026
0
15
Cryotherapy could be a game changer for patients with early-stage kidney cancer
Today, small kidney tumors are most often treated with a minor operation in which all or part of the kidney is removed. However, in many cases, these small tumors can be treated with targeted cryotherapy, which destroys the ...
Mar 5, 2026
0
7
